Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Radboud University Medical Center
With
Faculdade da Polícia Militar, Goiânia, GO - Brazil
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
To be eligible to participate in this study, the participant must meet the following criteria:
Be older than 18 years old. Observation: the elderly is at risk for severe forms of COVID-19, therefore, the evidence in this age group is very relevant. However, they can also be a first priority population to receive a specific vaccine, limiting the time to follow-up on the study. In addition, influenza and MMR vaccines can lead to a lower immune system in the elderly than in young people. Therefore, it is likely that a more rational choice will be to carry out the study in a young population.
You may not be if
Participants will not be included in the study if they present (reported by the research participants):
Known allergy to components of influenza and MMR vaccines or serious adverse events to previous administration.
Fever (\> 38 degrees Celsius) in the last 24 hours.
Pregnancy. Note: pregnancy should be avoided for one month after vaccination.
Symptoms of active viral or bacterial infection.
Documented diagnosis of COVID-19.
Vaccination in the last 4 weeks against SARS-CoV-2.
Immunocompromised participants. This exclusion category includes: a) infection with the human immunodeficiency virus (HIV-1); b) neutropenic participant with less than 500 neutrophils/mm3; c) participant with organ transplantation; d) participants with bone marrow transplantation; e) participants in chemotherapy treatment; f) participants with primary immunodeficiency; g) participants with severe lymphopenia with less than 400 lymphocytes/mm3; h) treatment with any anti-cytokine medication; i) treatment with oral or intravenous steroids, for example, daily doses of prednisone or equivalent for more than 3 months, or probable use of oral or intravenous steroids within next four weeks.
Some type of lymphoma or malignancy in the previous two years.
Direct involvement in the design or execution of the study.
Absence from work for more than 4 weeks within the next 12 weeks after study admission (vacation, maternity leave, retirement, planned surgery, etc.)
